Executive Vice President and Chief Accounting Officer of CCK sells 13,373 shares in insider sale

Gerard H Gifford, who holds the positions of EVP & CAO at the company $CCK, recently made headlines when he sold 13,373 shares of the company on February 20, 2026, for an estimated $1,524,187. This transaction, reported through a recent SEC filing, represented a significant portion of approximately 11.2% of their holdings in this particular class of stock. Post this sale, Gifford retains ownership of 106,310 shares of this class of $CCK stock.

Looking at the broader trend of insider trading within $CCK, insiders have been active in the market over the past 6 months, engaging in 6 trades during this period. Notably, there have been zero purchases but 6 sales of $CCK stock by key insiders. Timothy J Donahue, the President & CEO of the company, executed 4 sales transactions, divesting 52,500 shares for an estimated $5,555,109. Similarly, Djalm Jr Novaes, who holds the title of EVP & COO, parted ways with 19,754 shares for roughly $1,995,549.

Switching gears to hedge fund activity surrounding $CCK, 335 institutional investors displayed an interest in adding shares of the company to their portfolios, while 355 opted to reduce their positions in the most recent quarter. Amongst the notable moves, UBS AM, a distinct entity of UBS Asset Management Americas LLC, significantly decreased their holdings by removing 2,356,506 shares (-85.9%) in Q4 2025, with an estimated value of $242,649,422. Conversely, Qube Research & Technologies Ltd took a contrasting approach by adding 1,405,919 shares (+4766.8%) to their holdings in Q4 2025, valuing at approximately $144,767,479.

In more financial data regarding $CCK, the company reported revenues of $3.1 billion in Q4 2025, marking a notable 7.72% increase from the corresponding period in the previous year. To delve deeper into CCK’s financial landscape, interested parties can find related information on Quiver Quantitative’s dedicated CCK stock page.

Shifting attention to congressional stock trading activities, members of Congress were involved in one $CCK stock transaction over the past 6 months. Of these recorded trades, there were no purchases, with only 1 sale. Representative Val T. Hoyle made a sale of $15,000 on 09/23, showcasing limited congressional activity involving $CCK stock.

Regarding analyst ratings, Wall Street analysts have been active in monitoring $CCK, issuing a total of 6 buy ratings in recent months. Noteworthy analyst reports include UBS’ “Buy” rating on 01/12/2026 and Truist Securities’ “Buy” rating on 01/06/2026, signaling a positive sentiment towards $CCK’s performance in the market.

Lastly, multiple analysts have rolled out price targets for $CCK in recent times. A total of 9 analysts have presented price targets for the company in the last 6 months, with a median target of $124.0. Notable targets include Arun Viswanathan from RBC Capital setting a target of $140.0 on 02/09/2026 and Michael Roxland from Truist Securities establishing a target of $135.0 on 02/06/2026, among others. For comprehensive tracking of analyst ratings and price targets for $CCK, financial enthusiasts can turn to Quiver Quantitative’s $CCK forecast page for detailed insights.